Your Source for Venture Capital and Private Equity Financings

Amlogenyx Closes Successful Seed Funding

2024-08-02
NOVATO, CA, Amlogenyx Inc. has completed a seed funding round of $14 million.
GordonMD Global Investments LP announced that Amlogenyx Inc. has completed a seed funding round of USD 14 million. Amlogenyx, a subsidiary of Ultragenyx Pharmaceutical, Inc. (NASDAQ: RARE), is researching and developing novel gene therapies for Alzheimer's disease and other amyloid diseases.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors